MG
CDNA icon

Michael Gelband’s CareDx CDNA Stock Holding History

Michael Gelband’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.11M Buy
+214,342
New +$4.67M 0.04% 432
2026
Q1 		– Sell
-31,240
Closed -$589K – 1601
2025
Q4 		$589K Buy
+31,240
New +$523K ﹤0.01% 1150
2025
Q2 		– Sell
-45,943
Closed -$815K – 1507
2025
Q1 		$815K Sell
45,943
-29,804
-39% -$642K 0.01% 967
2024
Q4 		$1.62M Buy
75,747
+39,566
+109% +$962K 0.01% 793
2024
Q3 		$1.13M Buy
+36,181
New +$900K 0.01% 935
2024
Q1 		– Sell
-31,246
Closed -$375K – 1527
2023
Q4 		$375K Buy
+31,246
New +$256K ﹤0.01% 1115
2023
Q3 		– Sell
-31,960
Closed -$272K – 1743
2023
Q2 		$272K Sell
31,960
-27,506
-46% -$229K ﹤0.01% 1577
2023
Q1 		$544K Sell
59,466
-12,428
-17% -$159K ﹤0.01% 1314
2022
Q4 		$820K Buy
71,894
+16,928
+31% +$251K 0.01% 1013
2022
Q3 		$936K Buy
+54,966
New +$1.18M 0.01% 1134
2022
Q1 		– Sell
-6,225
Closed -$283K – 2232
2021
Q4 		$283K Buy
+6,225
New +$325K ﹤0.01% 1683
2021
Q3 		– Sell
-3,297
Closed -$302K – 2164
2021
Q2 		$302K Buy
+3,297
New +$262K ﹤0.01% 1739
2021
Q1 		– Sell
-32,367
Closed -$2.35M – 2150
2020
Q4 		$2.35M Sell
32,367
-9,377
-22% -$543K 0.02% 479
2020
Q3 		$1.58M Buy
41,744
+10,658
+34% +$360K 0.03% 481
2020
Q2 		$1.1M Buy
+31,086
New +$885K 0.03% 693
2020
Q1 		– Sell
-17,263
Closed -$372K – 1128
2019
Q4 		$372K Buy
+17,263
New +$396K 0.01% 1022
2019
Q3 		– Sell
-7,838
Closed -$282K – 1353
2019
Q2 		$282K Buy
+7,838
New +$251K 0.01% 727

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's CDNA Position: Q2 2026 in Review

Michael Gelband opened a new position in CareDx (CDNA) in Q2 2026: 214,342 shares worth $6.11M. The stake represents 0.04% of the portfolio and ranks #432 among its holdings. This is a return to the name: Michael Gelband previously reported a position in CDNA as recently as Q4 2025.

Michael Gelband first reported a position in CDNA in Q2 2019 and has held it in 17 quarters since. 225 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Michael Gelband held 214,342 shares of CareDx worth $6.11M as of Q2 2026.
  • CareDx was a new Michael Gelband position in Q2 2026.
  • CareDx made up 0.04% of Michael Gelband's portfolio in Q2 2026, its #432 holding.
  • Michael Gelband first reported a position in CareDx in Q2 2019 and has held it in 17 quarters since.
  • 225 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.